Correlation Between Pfizer and Saat Aggressive

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Saat Aggressive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Saat Aggressive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Saat Aggressive Strategy, you can compare the effects of market volatilities on Pfizer and Saat Aggressive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Saat Aggressive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Saat Aggressive.

Diversification Opportunities for Pfizer and Saat Aggressive

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and Saat is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Saat Aggressive Strategy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Saat Aggressive Strategy and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Saat Aggressive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Saat Aggressive Strategy has no effect on the direction of Pfizer i.e., Pfizer and Saat Aggressive go up and down completely randomly.

Pair Corralation between Pfizer and Saat Aggressive

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Saat Aggressive. In addition to that, Pfizer is 2.51 times more volatile than Saat Aggressive Strategy. It trades about -0.05 of its total potential returns per unit of risk. Saat Aggressive Strategy is currently generating about 0.09 per unit of volatility. If you would invest  1,191  in Saat Aggressive Strategy on August 31, 2024 and sell it today you would earn a total of  255.00  from holding Saat Aggressive Strategy or generate 21.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.73%
ValuesDaily Returns

Pfizer Inc  vs.  Saat Aggressive Strategy

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The new stock price tumult, may contribute to shorter-term losses for the shareholders.
Saat Aggressive Strategy 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Saat Aggressive Strategy are ranked lower than 11 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Saat Aggressive is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pfizer and Saat Aggressive Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Saat Aggressive

The main advantage of trading using opposite Pfizer and Saat Aggressive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Saat Aggressive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Saat Aggressive will offset losses from the drop in Saat Aggressive's long position.
The idea behind Pfizer Inc and Saat Aggressive Strategy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device